Leuthold Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,410
Closed -$2.97M 206
2021
Q3
$2.97M Buy
20,410
+64
+0.3% +$9.36K 0.36% 100
2021
Q2
$2.69M Sell
20,346
-354
-2% -$46.3K 0.33% 107
2021
Q1
$2.66M Sell
20,700
-4,787
-19% -$590K 0.34% 107
2020
Q4
$3.04M Sell
25,487
-1,082
-4% -$132K 0.4% 84
2020
Q3
$3.04M Sell
26,569
-548
-2% -$64.7K 0.42% 83
2020
Q2
$3.09M Sell
27,117
-749
-3% -$79.4K 0.46% 81
2020
Q1
$2.24M Buy
27,866
+24,532
+736% +$2.54M 0.4% 84
2019
Q4
$356K Buy
+3,334
New +$348K 0.05% 136
2019
Q2
Sell
-53,005
Closed -$4.77M 194
2019
Q1
$4.77M Sell
53,005
-2,367
-4% -$205K 0.64% 60
2018
Q4
$4.61M Sell
55,372
-6,650
-11% -$623K 0.66% 50
2018
Q3
$6.69M Sell
62,022
-1,135
-2% -$124K 0.73% 47
2018
Q2
$6.94M Sell
63,157
-77
-0.1% -$8.02K 0.76% 44
2018
Q1
$6.34M Buy
+63,234
New +$6.48M 0.72% 46
2016
Q1
Sell
-65,565
Closed -$4.66M 200
2015
Q4
$4.66M Buy
65,565
+18,940
+41% +$1.27M 0.49% 84
2015
Q3
$2.87M Buy
+46,625
New +$3.26M 0.3% 111
2014
Q2
Sell
-38,985
Closed -$2.26M 203
2014
Q1
$2.26M Buy
38,985
+11,628
+43% +$623K 0.2% 134
2013
Q4
$1.47M Buy
+27,357
New +$1.62M 0.13% 160
2013
Q3
Sell
-74,868
Closed -$4.54M 319
2013
Q2
$4.54M Buy
+74,868
New +$4.46M 0.42% 80

Other funds holding DGX

Leuthold Group's DGX Position: Q4 2021 in Review

Leuthold Group sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 20,410 shares — an estimated $2.97M sold.

Leuthold Group first reported a position in DGX in Q2 2013 and held it in 18 quarters. The position peaked at $6.94M in Q2 2018. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Leuthold Group reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Leuthold Group sold 20,410 Quest Diagnostics shares in Q4 2021, an estimated $2.97M.
  • Leuthold Group first reported a position in Quest Diagnostics in Q2 2013 and held it in 18 quarters.
  • Leuthold Group's Quest Diagnostics position peaked at $6.94M in Q2 2018.
  • 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Leuthold Group's 13F filing for Q4 2021, filed 3 Feb 2022.